Pharma Firms Told To ‘Keep Your Distance’ When Patients Come To EU CHMP Meetings
Executive Summary
The European Medicines Agency is planning to expand the involvement of patients in benefit-risk evaluation of medicines following a successful pilot, but one EU patient group has advised drug companies not to contact patients during their visits to the agency as this could lower the value of their input.